[144] SEMPRA SEC Filing
Rhea-AI Filing Summary
Sempra (SRE)
Positive
- None.
Negative
- None.
FAQ
What does Sempra (SRE)'s latest Form 144 filing disclose?
The Form 144 discloses a planned sale of 7,564 shares of Sempra common stock under Rule 144, with an aggregate market value of $699,670, to be sold on the NYSE.
How many Sempra (SRE) shares are planned to be sold and on which exchange?
The notice covers a proposed sale of 7,564 common shares of Sempra, expected to be sold on the New York Stock Exchange (NYSE).
What is the reported aggregate market value of the Sempra (SRE) shares in this Form 144?
The filing lists an aggregate market value of $699,670 for the 7,564 Sempra common shares covered by the planned Rule 144 sale.
How were the Sempra (SRE) shares in the Form 144 acquired?
The shares were acquired through vesting of restricted stock units under Sempra's Long-Term Incentive Plan, received as equity compensation on several vesting dates in 2025.
What portion of Sempra (SRE) shares is outstanding according to the Form 144?
The Form 144 states that 652,681,521 shares of Sempra common stock were outstanding at the time referenced in the filing.
When did the restricted stock units for Sempra (SRE) vest for the shares being sold?
The filing lists vesting dates of 01/02/2025 for 2,325 shares, 01/28/2025 for 1,000 shares, and 02/19/2025 for 4,239 shares, all as compensation awards.
Which broker is handling the planned Sempra (SRE) share sale under Rule 144?
The planned sale of 7,564 Sempra common shares is to be executed through Oppenheimer & Co., Inc. at its Los Angeles, California office.